Physician profile
Marc Sher
NPI 1376682443
$7,580.35
in general payments reported to CMS, 2019-2025
37 companies · $2,990 in 2025
The $2,990 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,941 · 2020: $113 · 2021: $218 · 2022: $330 · 2023: $463 · 2024: $525 · 2025: $2,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,222 · Food and Beverage: $1,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,222.21 |
| Food and Beverage | $1,755.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,733.56 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,374.31 | 2019 | |
| Dilon Technologies, INC. | $404.07 | 2023-2024 | Hemoblast Bellows |
| Ferring Pharmaceuticals INC. | $267.34 | 2019-2023 | Rebyota |
| Tei Biosciences INC | $237.66 | 2019 | |
| Biom'Up Sa | $196.12 | 2019 | |
| Ethicon US, LLC | $175.90 | 2020-2025 | Echelon; Endopath, Enseal, Echelon Circular |
| Astrazeneca Pharmaceuticals Lp | $133.60 | 2023-2024 | Lokelma, Andexxa |
| Aurinia Pharma U.S., INC. | $125.00 | 2024 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Thd America, INC. | $85.37 | 2020-2023 | |
| Abbvie INC. | $83.60 | 2022 | |
| Redhill Biopharma INC. | $69.52 | 2020-2022 | |
| Baxter Healthcare | $49.50 | 2025 | Tisseel |
| Tela Bio, INC. | $47.35 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Sher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.